Recalls
FDA Issues Final Guidance for Cell and Gene Therapy Potency Standards
The U.S. Food and Drug Administration issued final guidance on November 2, 2026, for manufacturers of cellular and gene therapy products to ensure their products meet potency standards. The guidance provides…
